Physician profile
Bernard L Markowitz
NPI 1912912346
$1,745.88
in general payments reported to CMS, 2019-2025
12 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $126 · 2023: $703 · 2024: $416 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,620.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $298.87 | 2023 | |
| Abbvie INC. | $217.16 | 2023-2024 | |
| Polynovo North America LLC | $175.20 | 2023 | |
| Integra Lifesciences Corporation | $158.84 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Avita Medical Americas, LLC | $149.99 | 2024 | |
| Stryker Corporation | $148.86 | 2025 | Na, Sonopet Iq |
| Allergan, INC. | $125.83 | 2022 | |
| Solventum Corporation | $120.16 | 2024 | Prevena, V.A.C. Simplace |
| Heron Therapeutics, INC. | $116.91 | 2025 | Zynrelef |
| Mentor Worldwide LLC | $115.91 | 2023 | Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Becton, Dickinson and Company | $76.91 | 2025 | Arista |
| Kci USA, INC. | $41.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Markowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.